Adult Reconstruction Hip and Knee Hip and Knee Replacement. Valley Bone and Joint Specialists
Orthopaedic Surgery
Dr. Salvatore G. Lacognata, DO
Salvatore Lacognata works in the field of Orthopaedic Surgery. He over the years received 5 awards: "Consulting Surgeon for Complex Hip & Knee Reconstruction", "Consultant Orthopedic Computer Assisted Surgery/Navigation", "Consultant", "Chairman of the Board" and "Consultant Healthcare Sector Managment & Ops, Devices, Biotech,". Dr. Salvatore G. Lacognata, DO accepts Medicare payments and is listed with Medicare.gov.
Schools
Kansas City Univ Of Medicine Bioscience College Of Osteopathic Medicine
Procedures Preformed
- Dressing and-or Debridement of Wound, Infection, or Burn (incl. Negative Pressure Wound Therapy)
- Hand and Wrist Fracture Treatment, Closed
- Hip Fracture and-or Dislocation Treatment, Closed
- Hip Fracture and-or Dislocation Treatment, Open
- View All
Conditions Treated
- Achilles Tendinitis
- Adhesive Capsulitis
- Ankle Sprain and Achilles Tendon Sprain or Rupture
- Ankylosing Spondylitis
- View All
Doctors Specialties
- Orthopedic Surgery
- Orthopaedic Surgery
Accepted Insurances
Awards
- Consulting Surgeon for Complex Hip & Knee Reconstruction
- Consultant Orthopedic Computer Assisted Surgery/Navigation
- Consultant
- Chairman of the Board
- Consultant Healthcare Sector Managment & Ops, Devices, Biotech,
Education
-
Kansas City University College of Osteopathic Medicine
Drug Facts
NPI NUMBER |
|
1609901057 |
NPPES Provider LastName |
|
LACOGNATA |
NPPES Provider FirstName |
|
SALVATORE |
NPPES Provider ZIPCode |
|
852064626 |
NPPES Provider State |
|
AZ |
Specialty Description |
|
Orthopedic Surgery |
Total Claim Count |
|
1016.0 |
Distinct Opioid Count |
|
6.0 |
Opioid Claim Count |
|
533.0 |
Percent Opioid Claims |
|
52.46 |
Helpful Reviews
Give
Anonymous Review
Medicare Facts
National Provider Identifier [NPI] |
1609901057 |
Last Name Of The Provider |
LACOGNATA |
First Name Of The Provider |
SALVATORE |
View All |
|
Similar Doctors
Doctor Directory | TOS | twitter | FB | Angel | blog